Table of Contents

Published: July 1, 2022

Read Time: 1.1 Mins

Total Views: 241

Publication Details

Authors: JK Varma

Year: 2022

Source: Drug Target Review

Publisher: drugtargetreview.com

Citations: 0

Citations per Year: 0

Google Scholar Rank: 141

Author Count: 1

Abstract

As humanity faces an impending era of pandemics, global collaboration among governments, organisations and industry is critical. In this article, epidemiologist Dr Jay Varma discusses the essential role of antiviral drug development in pandemic preparedness. This thoughtful commentary examines the critical importance of antiviral drug development in the new pandemic era, discussing the need for accelerated research and development, global collaboration, and strategic stockpiling of antiviral therapeutics to enhance pandemic preparedness and response capabilities for future infectious disease emergencies.

Key Findings

  • Critical importance of antiviral drug development for pandemic preparedness
  • Need for accelerated research and development processes
  • Global collaboration requirements among governments, organizations, and industry
  • Strategic stockpiling and distribution considerations for antiviral therapeutics
  • Framework for enhancing pandemic response capabilities through drug development

Research Impact

This recent commentary provided important perspectives on antiviral drug development priorities for pandemic preparedness, contributing to discussions about pharmaceutical research and development strategies for future infectious disease emergencies and global health security.

Publication Access

Full Text: Drug Target Review

Related Articles: Related Research

About the Author: Dr. Jay Varma

Dr. Jay Varma is a physician and public health expert with extensive experience in infectious diseases, outbreak response, and health policy.